Improving Sunitinib Efficacy and tolerability in patients with metastatic clear cell carcinoma of the kidney by using a 14/7 day schedule and ToxicityAdjusted Dosing (ISE TAD147)

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/07/15 → 1/07/17